Probiotics enhance intestinal health
- Stimulation of immunity
- Inhibition of bacterial epithelial and mucosal adherence
- Inhibition of bacterial epithelial invasion
- Production of antimicrobial substances
Abstract
The use of probiotics to enhance intestinal health has been proposed for many years. Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the prevention and treatment of specific pathologic conditions when they are ingested. There is a relatively large volume of literature that supports the use of probiotics to prevent or treat intestinal disorders. However, the scientific basis of probiotic use has been firmly established only recently, and sound clinical studies have begun to be published. Currently, the best-studied probiotics are the lactic acid bacteria, particularly Lactobacillus sp. and Bifidobacterium sp. However, other organisms used as probiotics in humans include Escherichia coli, Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., Propionibacterium sp. and various fungi. Some probiotic preparations contain mixtures of more than one bacterial strain. Probiotics have been examined for their effectiveness in the prevention and treatment of a diverse spectrum of gastrointestinal disorders such as antibiotic-associated diarrhea (including Clostridium difficile-associated intestinal disease), infectious bacterial and viral diarrhea (including diarrhea caused by rotavirus, Shigella, Salmonella, enterotoxigenic E. coli, Vibrio cholerae and human immunodeficiency virus/acquired immunodeficiency disorder, enteral feeding diarrhea, Helicobacter pylori gastroenteritis, sucrase maltase deficiency, inflammatory bowel disease, irritable bowel syndrome, small bowel bacterial overgrowth and lactose intolerance. Probiotics have been found to inhibit intestinal bacterial enzymes involved in the synthesis of colonic carcinogens. There are many mechanisms by which probiotics enhance intestinal health, including stimulation of immunity, competition for limited nutrients, inhibition of epithelial and mucosal adherence, inhibition of epithelial invasion and production of antimicrobial substances. Probiotics represent an exciting prophylactic and therapeutic advance, although additional investigations must be undertaken before their role in intestinal health can be delineated clearly.
Reference
Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000 Feb;130(2S Suppl):396S-402S. doi: 10.1093/jn/130.2.396S. PMID: 10721914
500 mg / 60 Vegetarian Capsules
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics.
1 capsule 1 time per day. Take at least 2-3 hours before or after antibiotics.
Medicinal Ingredients | Each Capsule Contains |
Probiotic Blend 10 Billion CFU | 500 mg |
Lactobacillus Acidophilus (LA85) | 1.01 X 10 8 CFU |
Lactobacillus Reuteri (LR08) | 1.01 X 108 CFU |
Ligilactobacillus Salivarius (LS03) | 1.01 X 108 CFU |
Lactobacillus Helveticus (LH76) | 2.02 X 108 CFU |
Lactobacillus Casei (LC89) | 6.06 X 108 CFU |
Lacticaseibacillus Paracasei (SP5) | 8.08 X 108 CFU |
Lactobacillus Rhamnosus (LRa05) | 1.21 X 109 CFU |
Lactiplantibacillus Plantarum (Lp90) | 1.52 X 109 CFU |
Lactobacillus Gasseri (LG08) | 2.02 X 108 CFU |
Lactobacillus Delbrueckii Subsp. Bulgaricus (LB42) | 6.06 X 108 CFU |
Lactobacillus Fermentum (LF61) | 2.02 X 108 CFU |
Lactococcus Lactis (LLa61) | 4.04 X 108 CFU |
Bifidobacterium Longum Subsp. Longum (BL21) | 8.08 X 108 CFU |
Bifidobacterium Breve (BBr60) | 1.01 X 109 CFU |
Bifidobacterium Animalis Subsp. Lactis (BB-12) | 1.11 X 109 CFU |
Bifidobacterium Bifidum (BBi32) | 1.01 X 109 CFU |
Fructooligosaccharides, Maltodextrin, Potato Starch, Magnesium Stearate, and Hypromellose.
Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).